PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1392033
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1392033
The global personalized genomics market size is expected to reach US$ 27.77 Billion by 2030, from US$ 9.14 Billion in 2023, at a CAGR of 17.2% during the forecast period.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2022 | Market Size in 2023: | US$ 9.14 Bn |
Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
Forecast Period 2023 to 2030 CAGR: | 17.20% | 2030 Value Projection: | US$ 27.77 Bn |
Personalized genomics is a rapidly growing field that combines genetics, genomics, and personalized medicine to provide individuals with valuable insights into their genetic makeup.
Market Dynamics:
The global personalized genomics market is driven by several factors. Firstly, the increasing prevalence of chronic diseases and the need for personalized treatment options have created a demand for genetic testing services. Personalized genomics can help identify individuals who are at a higher risk of developing certain diseases, allowing for early intervention and targeted treatment. For instance, in September 2020, according to an article published in Preventing Chronic Disease, in 2018, 51.8% of civilian, noninstitutionalized adults had been diagnosed with at least 1 of 10 selected chronic conditions. More specifically, the 24.6% of adults have 1 chronic condition, and 27.2% have more than two chronic conditions.
Additionally, advancements in technology, such as next-generation sequencing and bioinformatics, have made genetic testing more accessible and affordable. This has led to a growing consumer base for companies offering personalized genomics services.
However, there are also certain restraints in the market. Concerns about privacy and data security have been raised, as genetic information is highly sensitive and can be misused if not properly protected. Regulatory challenges and the need for clear guidelines regarding the use and interpretation of genetic data also pose challenges to market growth.
Despite these challenges, the personalized genomics market presents significant opportunities. The integration of artificial intelligence and machine learning algorithms in genetic analysis can enhance the accuracy and efficiency of personalized genomics services. Additionally, the expansion of direct-to-consumer genetic testing and the increasing adoption of genetic testing in healthcare settings offer promising growth prospects for companies in this market.
Personalized Genomics Market Detailed Segmentation: